| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 subunit AMP allosteric regulatory site
1 St. Vincent’s Institute of Medical Research, Fitzroy, Victoria 3065, Australia
2 Departments of Medicine and Biochemistry, Dartmouth Medical School, and Department of Biological Sciences, Dartmouth College, Hanover, New Hampshire 03755, USA
Reprint requests to: Bruce E. Kemp, St. Vincent’s Institute of Medical Research, 41 Victoria Parade, Fitzroy, Victoria 3065, Australia; e-mail: kemp{at}ariel.unimelb.edu.au; fax: 61-3-94162676.
AMP-activated protein kinase (AMPK) is a 
ß
heterotrimer that is activated in response to both hormones and intracellular metabolic stress signals. AMPK is regulated by phosphorylation on the subunit and by AMP allosteric control previously thought to be mediated by both and subunits. Here we present evidence that adjacent subunit pairs of CBS repeat sequences (after Cystathionine Beta Synthase) form an AMP binding site related to, but distinct from the classical AMP binding site in phosphorylase, that can also bind ATP. The AMP binding site of the 1 CBS1/CBS2 pair, modeled on the structures of the CBS sequences present in the inosine monophosphate dehydrogenase crystal structure, contains three arginine residues 70, 152, and 171 and His151. The yeast homolog, snf4 contains a His151Gly substitution, and when this is introduced into 1, AMP allosteric control is substantially lost and explains why the yeast snf1p/snf4p complex is insensitive to AMP. Arg70 in 1 corresponds to the site of mutation in human 2 and pig 3 genes previously identified to cause an unusual cardiac phenotype and glycogen storage disease, respectively. Mutation of any of AMP binding site Arg residues to Gln substantially abolishes AMP allosteric control in expressed AMPK holoenzyme. The Arg/Gln mutations also suppress the previously described inhibitory properties of ATP and render the enzyme constitutively active. We propose that ATP acts as an intrasteric inhibitor by bridging the and subunits and that AMP functions to derepress AMPK activity.
Keywords: AMPK; AMP; CBS sequences; subunit; allosteric and intrasteric control
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Momcilovic, S. H. Iram, Y. Liu, and M. Carlson Roles of the Glycogen-binding Domain and Snf4 in Glucose Inhibition of SNF1 Protein Kinase J. Biol. Chem., July 11, 2008; 283(28): 19521 - 19529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Iseli, J. S. Oakhill, M. F. Bailey, S. Wee, M. Walter, B. J. van Denderen, L. A. Castelli, F. Katsis, L. A. Witters, D. Stapleton, et al. AMP-activated Protein Kinase Subunit Interactions: {beta}1:{gamma}1 ASSOCIATION REQUIRES {beta}1 Thr-263 AND Tyr-267 J. Biol. Chem., February 22, 2008; 283(8): 4799 - 4807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Putman, K. J. B. Martins, M. E. Gallo, G. D. Lopaschuk, J. A. Pearcey, I. M. MacLean, R. J. Saranchuk, and D. Pette {alpha}-Catalytic subunits of 5'AMP-activated protein kinase display fiber-specific expression and are upregulated by chronic low-frequency stimulation in rat muscle Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1325 - R1334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-P. Hong and M. Carlson Regulation of Snf1 Protein Kinase in Response to Environmental Stress J. Biol. Chem., June 8, 2007; 282(23): 16838 - 16845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Carvajal, E. Zarrinpashneh, O. Szarszoi, F. Joubert, Y. Athea, P. Mateo, B. Gillet, S. Vaulont, B. Viollet, X. Bigard, et al. Dual cardiac contractile effects of the {alpha}2-AMPK deletion in low-flow ischemia and reperfusion Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3136 - H3147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Townley and L. Shapiro Crystal Structures of the Adenylate Sensor from Fission Yeast AMP-Activated Protein Kinase Science, March 23, 2007; 315(5819): 1726 - 1729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Barre, C. Richardson, M. F. Hirshman, J. Brozinick, S. Fiering, B. E. Kemp, L. J. Goodyear, and L. A. Witters Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E802 - E811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Ellingson, D. G. Chesser, and W. W. Winder Effects of 3-phosphoglycerate and other metabolites on the activation of AMP-activated protein kinase by LKB1-STRAD-MO25 Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E400 - E407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Birk and J. F. P. Wojtaszewski Predominant {alpha}2/{beta}2/{gamma}3 AMPK activation during exercise in human skeletal muscle J. Physiol., December 15, 2006; 577(3): 1021 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W. Dolinsky and J. R. B. Dyck Role of AMP-activated protein kinase in healthy and diseased hearts Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2557 - H2569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Beckers, S. Organe, L. Timmermans, F. Vanderhoydonc, L. Deboel, R. Derua, E. Waelkens, K. Brusselmans, G. Verhoeven, and J. V. Swinnen Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside. Mol. Cancer Ther., September 1, 2006; 5(9): 2211 - 2217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. B. Dyck and G. D. Lopaschuk AMPK alterations in cardiac physiology and pathology: enemy or ally? J. Physiol., July 1, 2006; 574(1): 95 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Jorgensen, E. A. Richter, and J. F. P. Wojtaszewski Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise J. Physiol., July 1, 2006; 574(1): 17 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gregor, A. Zeold, S. Oehler, K. A. Marobela, P. Fuchs, G. Weigel, D. G. Hardie, and G. Wiche Plectin scaffolds recruit energy-controlling AMP-activated protein kinase (AMPK) in differentiated myofibres J. Cell Sci., May 1, 2006; 119(9): 1864 - 1875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. B. Taylor, W. J. Ellingson, J. D. Lamb, D. G. Chesser, C. L. Compton, and W. W. Winder Evidence against regulation of AMP-activated protein kinase and LKB1/STRAD/MO25 activity by creatine phosphate Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E661 - E669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. B. Taylor, J. D. Lamb, R. W. Hurst, D. G. Chesser, W. J. Ellingson, L. J. Greenwood, B. B. Porter, S. T. Herway, and W. W. Winder Endurance training increases skeletal muscle LKB1 and PGC-1{alpha} protein abundance: effects of time and intensity Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E960 - E968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Fisher, J.-S. Ju, P. J. Oppelt, J. L. Smith, A. Suzuki, and H. Esumi Muscle contractions, AICAR, and insulin cause phosphorylation of an AMPK-related kinase Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E986 - E992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Mount, R. E. Hill, S. A. Fraser, V. Levidiotis, F. Katsis, B. E. Kemp, and D. A. Power Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-Ser1177 Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1103 - F1115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Frederich, L. Zhang, and J. A. Balschi Hypoxia and AMP independently regulate AMP-activated protein kinase activity in heart Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2412 - H2421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Iseli, M. Walter, B. J. W. van Denderen, F. Katsis, L. A. Witters, B. E. Kemp, B. J. Michell, and D. Stapleton AMP-activated Protein Kinase {beta} Subunit Tethers {alpha} and {gamma} Subunits via Its C-terminal Sequence (186-270) J. Biol. Chem., April 8, 2005; 280(14): 13395 - 13400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. Niemeyer, Y. R. Yusef, I. Cornejo, C. A. Flores, F. V. Sepulveda, and L. P. Cid Functional evaluation of human ClC-2 chloride channel mutations associated with idiopathic generalized epilepsies Physiol Genomics, September 16, 2004; 19(1): 74 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Barnes, S. Marklund, T. L. Steiler, M. Walter, G. Hjalm,, V. Amarger, M. Mahlapuu, Y. Leng, C. Johansson, D. Galuska, et al. The 5'-AMP-activated Protein Kinase {gamma}3 Isoform Has a Key Role in Carbohydrate and Lipid Metabolism in Glycolytic Skeletal Muscle J. Biol. Chem., September 10, 2004; 279(37): 38441 - 38447. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
